Jyong Biotech Ltd - MENS Trailing Twelve Months Revenue Growth

Brandmark of jyongbio.com (MENS)

Jyong Biotech Ltd (MENS) business is fully insulated from economic crises due to stable demand for medications. However, its micro-cap status and shortage of internal funds make the company dependent on external capital. The 12-month year-over-year revenue change history on GURU.Markets shows a development vector in urology, where the 0.00 mark captures the current state of the drug delivery platform implementation.

Jyong Bio (MENS) Sales Growth YoY (Last Twelve Months): for the period 11/23/2025 - 11/18/2026

Jyong Biotech - analytical breakdowns and key metrics (MENS)

- current price and projected stock value:
Summary company analytics:Jyong Biotech Corp (MENS)
Core merchandise of jyongbio.com

The success of Jyong Biotech Ltd (MENS) depends on the pace of regulatory approval for new drugs, rendering the business model high-risk. Current trailing 12-month revenue dynamics are calculated as the percentage change in total annual sales to neutralize seasonality. The value of 0.00 reflects the actual speed of the company's product commercialization. Steady growth in this indicator confirms the formation of an economic moat and reduces the probability of deep capital drawdowns.

Who Jyong Biotech Ltd competes with

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|LGND: Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) AMRX|Sales Growth YoY (Last Twelve Months) Perrigo Company|Trailing Twelve Months Revenue Growth Alvotech ALVO|Sales Growth YoY (TTM) LQDA|GLPG: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) ANIP (ANI Pharmaceuticals, Inc.)|Annual Revenue Growth (Last Twelve Months) MannKind Corp (MNKD)|AMPH: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last 12 Months) TBPH|AQST (Aquestive Corp) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) scPharmaceuticals Inc. (SCPH)|Revenue Growth YoY (Last 12 Months) TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) SXT Pharmaceuticals SXTC|Revenue Dynamics YoY (Last Twelve Months) EPRX|BHST - Sales Growth YoY (Last Twelve Months)|eXoZymes (EXOZ) - Revenue Growth YoY (Last 12 Months)|ORMP: Sales Growth YoY (TTM)|ENTX: Revenue Change YoY (Last 12 Months)|HYFT (ipatherapeutics.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) ABVC BioPharma|Sales Growth YoY (Last Twelve Months) Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Trailing Twelve Months Revenue Growth|RANI - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Synergy CHC SNYR|RLYB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Lexaria (LEXX)|Sales Growth YoY (Last Twelve Months) Pulmatrix|Sales Growth YoY (Last 12 Months) PTHL (ftzy.com.cn)|Sales Growth YoY (TTM) APM|Lyra Therapeutics, Inc. - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) IBO (impactbiomedinc.com)|TNFA: Sales Growth YoY (Last 12 Months)|YCBD - Sales Growth YoY (Last Twelve Months)|PRFX - Sales Growth YoY (TTM)|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)